The Quanterix Simoa® IL-17F Advantage PLUS Assay is designed for discovery and translational research applications requiring sensitive quantification of IL-17F in circulation. It supports biomarker studies focused on immunology, inflammation, respiratory disease, gastrointestinal disease, and chronic inflammatory disorders. The assay is particularly well suited for researchers who need high sensitivity, reproducibility, and cleaner longitudinal interpretation in low-abundance cytokine studies.
Research on chronic inflammatory disease:
Th17 pathway analysis:
Asthma and respiratory inflammation research:
Biomarker discovery and validation:
The Simoa® IL-17F Advantage PLUS Assay is positioned for use on the Quanterix HD-X and the Quanterix SR-X platforms.
Assay Performance
The Simoa® IL-17F Advantage PLUS Assay Kit includes all reagents and controls necessary to perform 96 tests, ensuring consistency and reliability in every run.
Researchers studying the IL-17 pathway can pair the Simoa® IL-17F Advantage PLUS Assay with the Simoa® IL-17A Advantage PLUS Assay to gain a more complete view of Th17-driven inflammation. Because IL-17A and IL-17F are closely related cytokines, that are often co-expressed, measuring both biomarkers can strengthen interpretation of IL-17 pathway activity in inflammatory disease research.
Neurology
There is no excerpt because this is a protected post.
Realizing the promise of multimodal diagnostics raises important questions: How should we think about integrating these different sources of information? Where can multimodal approaches add the most value? And what…
Disease is complex, dynamic, and heterogeneous, and no one biomarker modality can capture every dimension of that complexity. Liquid and tissue biomarkers answer different biological questions, each providing a distinct…
Cancer
Lung cancer is a formidable foe. Globally, it is the leading cause of cancer-related deaths in men and women, with non-small lung cancer (NSCLC) representing more than 80% of all…
The promise of proteomics lies in its ability to illuminate disease biology at scale, transform translational research, and guide the development of precision diagnostics and targeted therapies. While genomic technologies…
Translating proteomic discovery into clinical action requires more than scale, it demands precision, reproducibility, and quantitative clarity. The Quanterix Simoa® digital immunoassay technology was purpose-built to meet the demands of…
Molecular Barcoding Kit Now Available Globally; TIME and high-plex ADC panels confirmed for Q4 shipment; Accelerator Laboratory Services open custom ADC panel development BILLERICA, Mass.–September 25, 2026–Quanterix Corporation (NASDAQ: QTRX)…
BILLERICA, Mass.–September 14, 2026–Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of…
Reports $32.9 million in revenue and $96.9 million of cash and marketable securities Company accelerating initiatives to drive commercial effectiveness Revises financial outlook for 2026 and extends date for attaining…
Brings 20 years of senior commercial leadership in healthcare and IT, including GE Healthcare and Exact Sciences BILLERICA, Mass.–August 10, 2026–Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker…
BILLERICA, Mass. – August 6, 2026 – Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that senior management will participate in the Canaccord Genuity Capital…
BILLERICA, Mass. – August 4 2026 – Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that it will host a conference call on Monday, August…
BILLERICA, Mass. – June 16, 2026 – Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on June 15,…
Explore our library of resources, posts and materials.
Contact our team for customer support, distributor inquiries, or general questions.
